Dr. William Grady
I've won the following awards
Top Doctor, Seattle Metropolitan Magazine
Presidential Early Career Award for Scientists and Engineers, Department of Veterans Affairs
Damon Runyon-Lilly Clinical Investigator Award, Damon Runyon Cancer Research Foundation
Mallinckrodt Scholar Award, 42nd Scholar, Edward Mallinckrodt Jr. Foundation
John Walsh Memorial GIDH Award in Basic Research, John Walsh Memorial
DNA Methylation Profiling across the Spectrum of HPV-Associated Anal Squamous Neoplasia.
PLoS ONE., 7(11):e50533 (2012)
DNA methylation and gene expression profiling of ewing sarcoma primary tumors reveal genes that are potential targets of epigenetic inactivation.
Sarcoma., 2012:498472 (2012)
Therapeutic targeting of the phosphatidylinositol 3-kinase signaling pathway: novel targeted therapies and advances in the treatment of colorectal cancer.
Therap Adv Gastroenterol., Sep;5(5):319-37 (2012)
RET is a potential tumor suppressor gene in colorectal cancer.
Oncogene., Jul (2012)
Colorectal endoscopy, advanced adenomas, and sessile serrated polyps: implications for proximal colon cancer.
Am. J. Gastroenterol., Aug;107(8):1213-9 (2012)
Fbw7 and p53 cooperatively suppress advanced and chromosomally unstable intestinal cancer.
Mol. Cell. Biol., Jun;32(11):2160-7 (2012)
Epigenetic biomarkers in esophageal cancer.
Cancer Lett., Mar (2012)
Variation in age at cancer diagnosis in familial versus nonfamilial Barrett's esophagus.
Cancer Epidemiol. Biomarkers Prev., Feb;21(2):376-83 (2012)
Aberrantly methylated PKP1 in the progression of Barrett's esophagus to esophageal adenocarcinoma.
Genes Chromosomes Cancer., Apr;51(4):384-93 (2012)
DNA methylation profiling in Barrett's esophagus and esophageal adenocarcinoma reveals unique methylation signatures and molecular subclasses.
Epigenetics., Dec;6(12):1403-12 (2011)
Epigenetics and colorectal cancer.
Nat Rev Gastroenterol Hepatol., Dec;8(12):686-700 (2011)
Association of insulin and insulin-like growth factors with Barrett's oesophagus.
Gut., May;61(5):665-72 (2012)
Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
Hepatology., Jan;55(1):121-31 (2012)
Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry.
J Mol Diagn., May;13(3):271-81 (2011)
Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations.
Ann. Surg. Oncol., Aug;18(8):2338-47 (2011)
Linking epidemiology to epigenomics--where are we today?
Cancer Prev Res (Phila)., Dec;3(12):1505-8 (2010)
Colorectal cancer molecular biology moves into clinical practice.
Gut., Jan;60(1):116-29 (2011)
Use of folic acid-containing supplements after a diagnosis of colorectal cancer in the Colon Cancer Family Registry.
Cancer Epidemiol. Biomarkers Prev., Aug;19(8):2023-34 (2010)
The next thing in prognostic molecular markers: microRNA signatures of cancer.
Gut., Jun;59(6):706-8 (2010)
Insights into the role of DNA methylation in disease through the use of mouse models.
Dis Model Mech., 3(5-6):290-7 (2010 May-Jun)